Alfuzosin Spirig HC retard 10 mg

Alfuzosin Spirig HC retard 10 mg is a medicine authorised by Swissmedic under authorisation number 70609. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 09 December 2025 and the authorisation is valid without a time limit. ATC code G04CA01 places the medicine in the group Urologicals.

  • Dispensing category B
  • Authorisation number 70609
  • ATC G04CA01
  • Synthetic medicines
Authorisation data
Authorisation number70609
NameAlfuzosin Spirig HC retard 10 mg
Full nameAlfuzosin Spirig HC retard 10 mg, Retardtabletten
Authorisation holderSpirig HealthCare AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeG04CA01
First authorisation09 December 2025
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Alfuzosin Spirig HC retard 10 mg, RetardtablettenB09 December 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
110Tablette(n)G04CA0105.99.0.B
230Tablette(n)G04CA0105.99.0.B
390Tablette(n)G04CA0105.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Alfuzosin Spirig HC retard 10 mg authorised in Switzerland?

Yes. Alfuzosin Spirig HC retard 10 mg is authorised by Swissmedic under authorisation number 70609, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Alfuzosin Spirig HC retard 10 mg have?

Alfuzosin Spirig HC retard 10 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Alfuzosin Spirig HC retard 10 mg?

The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com